Cannon Global Investment Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,200
Closed -$69.5K 71
2024
Q1
$69.5K Buy
+24,200
New +$69.5K 0.19% 56